Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Frontiers of Medicine
Metadata
Title
Targeting apoptosis to manage acquired resistance to third generation EGFR inhibitors
Author
Shi-Yong Sun
Publication date
24-09-2022
Publisher
Higher Education Press
Published in
Frontiers of Medicine / Issue 5/2022
Print ISSN: 2095-0217
Electronic ISSN: 2095-0225
DOI
https://doi.org/10.1007/s11684-022-0951-0

Other articles of this Issue 5/2022

Frontiers of Medicine 5/2022 Go to the issue

Research Article

Increased expression of coronin-1a in amyotrophic lateral sclerosis: a potential diagnostic biomarker and therapeutic target

Review

Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives

Research Article

Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in GNAQ/11-mutant uveal melanoma

Research Article

Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors

Research Article

Mycophenolate mofetil or tacrolimus compared with azathioprine in long-term maintenance treatment for active lupus nephritis

Review

Recent advances in systemic lupus erythematosus and microbiota: from bench to bedside